or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    NVO C -2.07 2.70
    TM F -1.04 1.51
    NVS B 0.51 1.51

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Animal Health Anti Diabetic Drugs Antibiotics Auto Parts Automotive Industry Biopharmaceutical Biotechnology Blood Test Cars Contact Lens Contact Lenses Diabetes Diabetes Care Diagnostic Products Disposable Product Disposable Products Drugs E Commerce Marketplace Endocrine System
    Industries: Auto Manufacturers Biotechnology Drug Manufacturers - Major

    Recent News for Franklin International Core Dividend Tilt Index ETF & its Holdings

    Date Stock Title
    Jul 11 NVO Novo Nordisk once-weekly insulin rejected by FDA
    Jul 11 TM Tesla's US EV market share dips below 50% in Q2 as Ford, Kia, BMW see growth
    Jul 11 NVO After AdCom rejection, FDA rebuffs Novo Nordisk’s once-weekly insulin
    Jul 11 NVO Novo Nordisk (NVO) Soars 38% YTD: How Should You Play the Stock?
    Jul 11 NVO Novo (NVO) Gets CRL From FDA for Weekly Basal Insulin Icodec
    Jul 11 NVO Pfizer pushes ahead with once-a-day weight-loss pill
    Jul 11 NVO FDA Rejects Novo Nordisk's Weekly Insulin, Requests Information Related To Manufacturing Process, Type 1 Diabetes
    Jul 11 NVO Pfizer’s Weight-Loss Pill is Back. It’s Too Little, Too Late.
    Jul 11 TM The Journey Continues: Toyota Publishes 2024 North American D+I Annual Report
    Jul 11 NVO Examining Three Stocks With Intrinsic Discounts Ranging From 16.6% To 47.9%
    Jul 11 NVO Pfizer stock leaps on obesity drug challenge to Ozempic, Zepbound
    Jul 11 NVO Update: Market Chatter: Novo Nordisk Partners with Bio Farma to Package Insulin in Indonesia
    Jul 11 NVO Novo’s once-weekly insulin rejected by FDA
    Jul 11 TM Toyota (TM) Partners With IONNA to Boost EV Infrastructure
    Jul 11 TM Toyota joins Ionna charging network in US & Canada
    Jul 11 NVO The Zacks Analyst Blog Highlights Novo Nordisk, AbbVie, AstraZeneca, Air T and United-Guardian
    Jul 11 NVO Jim Cramer Identifies Eight Companies Eyeing Trillion-Dollar Club — Elon Musk's Tesla, Eli Lilly Top Contenders
    Jul 10 NVO Novo Nordisk receives Complete Response Letter in the US for once-weekly basal insulin icodec
    Jul 10 NVO FTC plans to sue top 3 PBMs over insulin prices: WSJ
    Jul 10 NVO Top Stock Reports for Novo Nordisk, AbbVie & AstraZeneca
    Franklin International Core Dividend Tilt Index ETF is an exchange traded fund launched by Franklin Resources, Inc. The fund is managed by Franklin Advisory Services, LLC. It invests in public equity markets of global ex-US/Canada region. The fund invests in stocks of companies operating across diversified sectors. The fund invests in value, momentum and less volatile stocks of companies across diversified market capitalization. It invests in dividend paying stocks of companies. The fund seeks to track the performance of the Morningstar Developed Markets ex-North America Dividend Enhanced Select Index, by using full replication technique. Franklin International Core Dividend Tilt Index ETF was formed on June 1, 2016 and is domiciled in the United States.
    Exchange Traded Funds SPDR Dividend S&P 500 Dividend Aristocrats
    Back to the Main DIVI Page...